Nuvalent, a US biopharma developing precisely targeted therapies for clinically-proven kinase targets in cancer, has ...

Sciwind Biosciences has shared late-stage trial data for its injectable GLP-1 therapy, signaling Chinese firms’ intensifying ...

US biotech Nektar Therapeutics experienced a remarkable 130% increase in its share price, which reached $21.9, as it reported ...

See-sawing global tariffs, a US regulator in flux and a possible end to US drug price premia are not, apparently, enough to ...

The US Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan or Dato-DXd) to treat adults with ...

New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its ...

The revision of the European pharmaceutical legislation, the reform of the Supplementary Protection Certificate (SPC) system ...

AI precision-medicine company Sonrai Analytics and German biotech Plectonic Biotech have entered a partnership to accelerate ...

Obesity late-comer Amgen announced full results from Part 1 of the Phase II study of MariTide (maridebart cafraglutide, ...

Danish diabetes and obesity giant Novo Nordisk yesterday announced that it will no longer be working with Hims & Hers Health ...

Swiss pharma giant Roche has announced positive Phase I/II data on NXT007 in people with hemophilia A, supporting its ...

Licensing of innovator oligonucleotide drugs for central nervous system (CNS) indications surged 339% in 2024, jumping from ...